Tag: Johnson & Johnson
Japan Watchdog Raids Johnson & Johnson’s Over Alleged Antitrust Violation
The Japan unit of US pharmaceutical giant Johnson & Johnson and a Tokyo-based firm selling medical products were searched by the country’s antitrust watchdog...
Pfizer, Johnson & Johnson Settle High-Profile Remicade Antitrust Suit
For nearly four years, pharmaceutical heavyweights Johnson & Johnson and Pfizer have sparred in court over competitive dynamics of the biosimilar industry, demanding the attention...
Johnson & Johnson To Buy Heart Pump Maker Abiomed in $16.6B
Johnson & Johnson said on Tuesday it struck a deal to buy heart pump maker Abiomed for $16.6 billion in cash, as it looks...
J&J, Remicade Antitrust Settlement Gets Green Light
Pension funds leading antitrust litigation against Johnson & Johnson (J&J) unit Janssen Biotech won preliminary approval from a federal judge in Philadelphia for a $25...
Johnson & Johnson Settles Contacts Antitrust Case
Johnson & Johnson Vision Care Inc has agreed to pay $55 million to end an antitrust case in US federal court over the pricing...
J&J Settles Antitrust Case Over Autoimmune Drug
Johnson & Johnson affiliates will pay $25 million to end antitrust litigation over their alleged scheme to delay generic versions of the anti-inflammatory Remicade, a...
Pfizer, Johnson & Johnson Settle Remicade Antitrust Suit
Pfizer settled with Johnson & Johnson, ending a four-year battle over J&J’s alleged use of exclusionary contracts to block biosimilar competition to its immunosuppressive...
US: J&J says FTC probing efforts to protect arthritis drug Remicade
The Federal Trade Commission (FTC) issued civil subpoenas to Johnson & Johnson (J&J) in June as part of an investigation into whether contracting practices...
US: J&J can’t arbitrate Remicade antitrust case argues Rochester
A drug wholesaler is urging a federal appeals court to not send a lawsuit accusing Johnson & Johnson (J&J) of seeking to suppress competition...
Canada: Competition Bureau completes investigation of Janssen
The Competition Bureau announced Wednesday, February 20, that it closed an investigation into allegations of abuse of dominance by Janssen, a Canadian pharmaceutical company...
